High rate of rubella seronegativity in perinatally-infected HIV women of childbearing age: A case-control study.
暂无分享,去创建一个
S. De Wit | S. Van den Wijngaert | P. Barlow | M. Hainaut | N. Dauby | M. Delforge | T. Grammens | Abraham J Beun
[1] R. Veazey,et al. Impaired Development and Expansion of Germinal Center Follicular Th Cells in Simian Immunodeficiency Virus–Infected Neonatal Macaques , 2018, The Journal of Immunology.
[2] P. Goulder,et al. Recovery of effective HIV-specific CD4+ T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia , 2018, AIDS.
[3] A. Sohn,et al. The global epidemiology of adolescents living with HIV: time for more granular data to improve adolescent health outcomes , 2018, Current opinion in HIV and AIDS.
[4] S. De Wit,et al. Prevalence and risk factors of measles seronegativity in a cohort of HIV‐positive subjects: a retrospective study , 2018, HIV medicine.
[5] D. Harris,et al. Immunity After Childhood Vaccinations in Perinatally HIV-exposed Children With and Without HIV Infection in Latin America , 2017, The Pediatric infectious disease journal.
[6] B. Chohan,et al. Sustained Responses to Measles Revaccination at 24 Months in HIV-infected Children on Antiretroviral Therapy in Kenya , 2017, The Pediatric infectious disease journal.
[7] P. Offit,et al. Plotkin's Vaccines , 2017 .
[8] C. Rizzo,et al. Global seroprevalence of rubella among pregnant and childbearing age women: a meta-analysis , 2017, European journal of public health.
[9] C. Strassburg,et al. Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany , 2016, Epidemiology and Infection.
[10] N. French,et al. British HIV Association Guidelines on the Use of Vaccines in HIV‐Positive Adults 2015 , 2016, HIV medicine.
[11] C. Bergin,et al. High levels of susceptibility to measles, mumps and rubella (MMR) in HIV-infected individuals in Ireland. , 2016, The Journal of infection.
[12] H. Young,et al. Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA , 2016, Journal of the International AIDS Society.
[13] M. Majigo,et al. Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review , 2015, BMC Research Notes.
[14] A. Rieger,et al. High need for MMR vaccination in HIV infected adults in Austria. , 2014, Vaccine.
[15] P. Böelle,et al. Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] P. Heath,et al. Guidance on vaccination of HIV‐infected children in Europe , 2012, HIV medicine.
[17] N. Low,et al. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. , 2011, The Journal of infectious diseases.
[18] R. Succi,et al. Pregnancy in HIV vertically infected adolescents and young women: a new generation of HIV-exposed infants , 2010, AIDS.
[19] L. Aurpibul,et al. Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] J. Best,et al. RUBELLA VACCINES , 1979, The Lancet.